Aurobindo Pharma zooms on getting USFDA’s nod for Flucytosine Capsules

04 May 2020 Evaluate

Aurobindo Pharma is currently trading at Rs. 667.50, up by 41.55 points or 6.64% from its previous closing of Rs. 625.95 on the BSE.

The scrip opened at Rs. 618.85 and has touched a high and low of Rs. 681.00 and Rs. 605.05 respectively. So far 421142 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 829.90 on 02-May-2019 and a 52 week low of Rs. 281.15 on 23-Mar-2020.

Last one week high and low of the scrip stood at Rs. 681.00 and Rs. 605.05 respectively. The current market cap of the company is Rs. 39105.54 crore.

The promoters holding in the company stood at 51.87%, while Institutions and Non-Institutions held 34.60% and 13.53% respectively.

Aurobindo Pharma has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Flucytosine Capsules, 250 mg and 500 mg. Flucytosine Capsules are generic version of Bausch Health’s Ancobon Capsules. The product will be launched in June 2020. Flucytosine Capsules are indicated for the treatment of serious infections caused by susceptible strains of Candida and/or Cryptococcus.

This is the 3rd ANDA to be approved out of APL Healthcare formulation facility in Hyderabad, India used for manufacturing oral products. The company now has a total of 429 ANDA approvals (401 Final approvals including 23 from Aurolife Pharma LLC and 28 tentative approvals) from USFDA.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1209.90 16.85 (1.41%)
18-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.35
Dr. Reddys Lab 1279.60
Cipla 1499.10
Zydus Lifesciences 913.85
Lupin 2118.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×